HNHeinrich Neubauer

Heinrich Neubauer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Heinrich Neubauer has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Determination of Antimicrobial Sensitivities of Campylobacter jejuni Isolated from Commercial Turkey Farms in Germany

    by Hosny El-Adawy, Helmut Hotzel, Sabine Düpre, Herbert Tomaso, Heinrich Neubauer, Hafez M. Hafez

  • Development of a diagnostic multiplex polymerase chain reaction microarray assay to detect and differentiate Brucella spp.

    by Gernot Schmoock, Ralf Ehricht, Falk Melzer, Mandy Elschner, Herbert Tomaso, Heinrich Neubauer, Sascha Al Dahouk


  • Open Access

    Molecular characterization of Coxiella burnetii isolates by infrequent restriction site-PCR and MLVA typing

    by Nathalie Arricau-Bouvery, Yolande Hauck, Awatef Bejaoui, Dimitrios Frangoulidis, Christelle C Bodier, Armel Souriau, Hermann Meyer, Heinrich Neubauer, Annie Rodolakis, Gilles Vergnaud

    Background: Coxiella burnetii, the causative agent of Q fever, has a wide host range. Few epidemiological tools are available, and they are often expensive or not easily standardized across laboratories. In this work,C. burnetiiisolates from livestock and ticks were typed using infrequent restriction site-PCR (IRS-PCR) and multiple loci variable number of tandem repeats (VNTR) analysis (MLVA).Results: By applying IRS-PCR, 14C. burnetiiisolates could be divided into six groups containing up to five different isolates. Clustering as deduced from MLVA typing with 17 markers provided an increased resolution with an excellent agreement to IRS-PCR, and with the plasmid type of each strain. MLVA was then applied to 28 additionalC. burnetiiisolates of different origin and 36 different genotypes were identified among the 42 isolates investigated. The clustering obtained is in agreement with published Multiple Locus Sequence Typing (MLST) data. Two panels of markers are proposed, panel 1 which can be confidently typed on agarose gel at a lower cost and in any laboratory setting (10 minisatellite markers with a repeat unit larger than 9 bp), and panel 2 which comprises 7 microsatellites and provides a higher discriminatory power.Conclusion: Our analyses demonstrate that MLVA is a powerful and promising molecular typing tool with a high resolution and of low costs. The consistency of the results with independent methods suggests that MLVA can be applied for epidemiological studies. The resulting data can be queried on a dedicated MLVA genotyping Web service.


  • Top Cited Papers
    Open Access

    Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay

    by Philippe Le Flèche, Isabelle Jacques, Maggy Grayon, Sascha Al Dahouk, Patrick Bouchon, France Denoeud, Karsten Nöckler, Heinrich Neubauer, Laurence A Guilloteau, Gilles Vergnaud

    Background: The classification of Brucella into species and biovars relies on phenotypic characteristics and sometimes raises difficulties in the interpretation of the results due to an absence of standardization of the typing reagents. In addition, the resolution of this biotyping is moderate and requires the manipulation of the living agent. More efficient DNA-based methods are needed, and this work explores the suitability of multiple locus variable number tandem repeats analysis (MLVA) for both typing and species identification. Results: Eighty tandem repeat loci predicted to be polymorphic by genome sequence analysis of three available Brucella genome sequences were tested for polymorphism by genotyping 21 Brucella strains (18 reference strains representing the six 'classical' species and all biovars as well as 3 marine mammal strains currently recognized as members of two new species). The MLVA data efficiently cluster the strains as expected according to their species and biovar. For practical use, a subset of 15 loci preserving this clustering was selected and applied to the typing of 236 isolates. Using this MLVA-15 assay, the clusters generated correspond to the classical biotyping scheme of Brucella spp. The 15 markers have been divided into two groups, one comprising 8 user-friendly minisatellite markers with a good species identification capability (panel 1) and another complementary group of 7 microsatellite markers with higher discriminatory power (panel 2). Conclusion: The MLVA-15 assay can be applied to large collections of Brucella strains with automated or manual procedures, and can be proposed as a complement, or even a substitute, of classical biotyping methods. This is facilitated by the fact that MLVA is based on non-infectious material (DNA) whereas the biotyping procedure itself requires the manipulation of the living agent. The data produced can be queried on a dedicated MLVA web service site.


  • Serodiagnosis of Burkholderia mallei Infections in Horses: State‐of‐the‐art and Perspectives

    by H. Neubauer, L. D. Sprague, R. Zacharia, H. Tomaso, S. Al Dahouk, R. Wernery, U. Wernery, H. C. Scholz

    Summary: Burkholderia mallei causes glanders or farcy in solipeds, a disease that must be reported to the OIE (Office International des Epizooties, Paris, France). The number of reported outbreaks has increased steadily during the last decade. Serodiagnosis is hampered by the considerable number of false‐positives and ‐negatives of the internationally prescribed tests. The major problem leading to low sensitivity and specificity of complement fixation test (CFT) and enzyme‐linked immunosorbent assay (ELISA) has been linked to the test antigens currently used, i.e. crude preparations of whole cells. Future perspectives for the development and evaluation of serological test kits using well‐characterized single antigens are discussed in the light of recent molecular research on B. mallei and the closely related saprozoonotic agent B. pseudomallei.


  • Prevalence of Anti-Yersinia Outer Protein Antibodies in Goats in Lower Saxony

    by K. Nikolaou, A. Hensel, C. Bartling, H. Tomaso, T. Arnold, U. Rosler, M. Ganter, T. Petry, H. Neubauer

    Little is known about the prevalence of caprine yersiniosis in Germany. Only few cases are reported every year. The intention of the survey was to provide representative data on the seroprevalence of anti-Yersinia antibodies in goats in the German state of Lower Saxony. A commercially available Western blot kit was used to identify caprine and ovine anti-Yersinia antibodies against five proteins [YopM, H, D, E and V-antigen (V-Ag)]. Of the 681 investigated goat sera, 449 (66%) had anti-Yop/V-Ag antibodies. Only two of 28 animal holdings housed sero-negative goats. Boxplot analysis showed that the number of non-reactive animals is correlated to the size of a herd and the fact of milk production, respectively. A tendency was observed that various management factors may influence the anti-Yersinia antibody status. No statement was possible on the impact of keeping additional carrier animals such as pigs, cows or sheep on a farm or the type of husbandry on the seroprevalence of anti-Yersinia antibodies. This study provides trend-setting data for yersiniosis in goat-holdings. The impact on consumer health, i.e. especially for risk groups-like people allergic to cow milk and the impact on the profit of a farm will have to be elucidated in further studies.


    • 9 December 2004
      • Vol. 117, 499-507

    [The prevalence of Yersinia-specific antibodies in cattle in Bavaria].

    by Carsten Bartling, Uwe Truyen, Gisela Isa, Heinrich Neubauer

    Yersiniosis is considered to be an emerging infection in humans. It is believed that contaminated pork is the main source of infection for man but also beef and cow milk might cause infection in the consumer. Therefore, a survey was carried out to obtain actual data on the prevalence of anti-Yersinia antibodies within cattle. 600 serum samples were taken form 120 farms located in 43 districts of Bavaria, Germany. Antibodies were detected in 396 animals (65.7%) revealing a distribution of 52.3% of anti-YopD, 40.3% of anti-YopM, 24.0% of anti-YopH, 21.2% of anti-YopE and 3.0% of anti-V-antigen antibodies. 21 reactionpatterns out of 32 possible patterns were identified. Anti-YopD and YopM antibodies were sufficient to detect all Yersinia antibody positive sera. No regional differences in the distribution of antibodies were noted.


  • Open Access

    Tandem repeats analysis for the high resolution phylogenetic analysis of Yersinia pestis

    by C Pourcel, F André-Mazeaud, H Neubauer, F Ramisse, G Vergnaud

    Yersinia pestis, the agent of plague, is a young and highly monomorphic species. Three biovars, each one thought to be associated with the last three Y. pestis pandemics, have been defined based on biochemical assays. More recently, DNA based assays, including DNA sequencing, IS typing, DNA arrays, have significantly improved current knowledge on the origin and phylogenetic evolution of Y. pestis. However, these methods suffer either from a lack of resolution or from the difficulty to compare data. Variable number of tandem repeats (VNTRs) provides valuable polymorphic markers for genotyping and performing phylogenetic analyses in a growing number of pathogens and have given promising results for Y. pestis as well. In this study we have genotyped 180 Y. pestis isolates by multiple locus VNTR analysis (MLVA) using 25 markers. Sixty-one different genotypes were observed. The three biovars were distributed into three main branches, with some exceptions. In particular, the Medievalis phenotype is clearly heterogeneous, resulting from different mutation events in the napA gene. Antiqua strains from Asia appear to hold a central position compared to Antiqua strains from Africa. A subset of 7 markers is proposed for the quick comparison of a new strain with the collection typed here. This can be easily achieved using a Web-based facility, specifically set-up for running such identifications. Tandem-repeat typing may prove to be a powerful complement to the existing phylogenetic tools for Y. pestis. Typing can be achieved quickly at a low cost in terms of consumables, technical expertise and equipment. The resulting data can be easily compared between different laboratories. The number and selection of markers will eventually depend upon the type and aim of investigations.


    • 18 February 2004
      • Vol. 117, 30-8

    [The prevalence of anti-yersinia outer protein antibodies in Bavarian slaughter pigs].

    by Andreas Hensel, Konstantinos Nikolaou, Carsten Bartling, Torsten Petry, Thorsten Arnold, Uwe Rösler, Claus-Peter Czerny, Uwe Truyen, Heinrich Neubauer

    The aim of the present study was to provide current data on the prevalence of anti-Yersinia-antibodies in Bavarian slaughtering pigs. The recomBlot Westernblot assay based on five recombinantly produced Yersinia Outer Proteins (YopD, YopE, YopH, YopM, V-antigen) is well evaluated for the use in the diagnosis of human yersiniosis and proved to be also a valuable tool for the detection of porcine antibodies. 965 out of 1002 meat juice samples collected in 53 Bavarian pig farms contained anti-Yop/V-Ag-antibodies. Only blots with three or more detectable signals were considered as positive. On the basis of these results a possible previous history of Yersinia infection was detected in 45.4% of the pigs and all of the pig farms. The high prevalence of anti-Yersinia-antibodies found in this investigation demonstrates the need for further epidemiological surveillance and animal studies to assess consumers' endangering.


    • 1 January 2004
      • Vol. 50, 387-94

    The detection of Brucella spp. using PCR-ELISA and real-time PCR assays.

    by Sascha Al Dahouk, Herbert Tomaso, Karsten Nöckler, Heinrich Neubauer

    Brucellosis is a worldwide 're-emerging' zoonosis causing high economic losses and severe human disease. Consequently, rapid and reliable, sensitive and specific, easy to perform and automated detection systems for Brucella spp. are urgently needed to allow early diagnosis and adequate antibiotic therapy in time. Real-time PCR assays using hybridization probes meet all these requirements. In 2003 various assays have been developed and evaluated for use in human and animal brucellosis. Genus-specific real-time PCR assays e.g. based on the bcsp31 gene will lead to an early diagnosis but for the purpose of epidemiological surveillance a species-specific real-time PCR deriving from the conventional AMOS (AbortusMelitensisOvisSuis)-PCR is necessary. Advantages and disadvantages of the different methods for real-time detection of Brucella spp. and a newly developed PCR-ELISA system for the high throughput of clinical samples will be discussed.